Bovie Medical Corporation , a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, announced today that it has closed its previously-announced registered underwritten public offering of 4,800,000 shares of its common stock at a price to the public of $2.50 per share.
from Google News, Yahoo! News, Wikinews, NY Times National News by search term http://ift.tt/1FvBrQR
via IFTTT
from Google News, Yahoo! News, Wikinews, NY Times National News by search term http://ift.tt/1FvBrQR
via IFTTT
No comments:
Post a Comment